Addendum: BOB CAT - Nature

Errata, Corrigenda, Retractions and Addenda

Corrigendum: Oral Prolonged Release Beclomethasone Dipropionate and Prednisone in the Treatment of Active Ulcerative Colitis: Results From a Double-Blind, Randomized, Parallel Group Study Gert Van Assche, Francesco Manguso, Marco Zibellini, José Luis Cabriada Nuño, Adrian Goldis, Evgeniy Tkachenko, Guido Varoli, Dariusz Kleczkowski, Vito Annese, François D’Heygere, Antonio Balzano and on behalf of the BETA study participating centers Am J Gastroenterol 2015; 110:708–715; doi: 10.1038/ajg.2015.114; published online 14 April 2015 In the Conflict of Interest section, the last sentence of the Specific Author Contributions incorrectly stated: Marco Zibellini and Gert Van Assche are representatives of Chiesi Farmaceutici S.p.A. (sponsor), Parma, Italy, and helped in the planning and organization of the study. It should read: Marco Zibellini and Guido Varoli are representatives of Chiesi Farmaceutici S.p.A. (sponsor), Parma, Italy, and helped in the planning and organization of the study.

Addendum: BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia Cathy Bennett, Paul Moayyedi, Douglas A. Corley, John DeCaestecker, Yngve Falck-Ytter, Gary Falk, Nimish Vakil, Scott Sanders, Michael Vieth, John Inadomi, David Aldulaimi, Khek-Yu Ho, Robert Odze, Stephen J. Meltzer, Eamonn Quigley, Stuart Gittens, Peter Watson, Giovanni Zaninotto, Prasad G. Iyer, Leo Alexandre, Yeng Ang, James Callaghan, Rebecca Harrison, Rajvinder Singh, Pradeep Bhandari, Raf Bisschops, Bita Geramizadeh, Philip Kaye, Sheila Krishnadath, M. Brian Fennerty, Hendrik Manner, Katie S. Nason, Oliver Pech, Vani Konda, Krish Ragunath, Imdadur Rahman, Yvonne Romero, Richard Sampliner, Peter D. Siersema, Jan Tack, Tony C.K. Tham, Nigel Trudgill, David S. Weinberg, Jean Wang, Kenneth Wang, Jennie Y.Y. Wong, Stephen Attwood, Peter Malfertheiner, David MacDonald, Hugh Barr, Mark K. Ferguson, Janusz Jankowski and the BOB CAT Consortium Am J Gastroenterol 2015; 110:xx–xx; doi:10.1038/ajg.2015.55 NICE has accredited the process used by the BOB CAT Consortium to produce its ‘BOB CAT: A Large-Scale Review and Delphi Consensus for Management of Barrett’s Esophagus With No Dysplasia, Indefinite for, or Low-Grade Dysplasia’ guidance. Accreditation is valid for 5 years. More information on accreditation can be viewed at www.evidence.nhs.uk. For full details on our accreditation visit www.nice.org.uk/accreditation.

© 2015 by the American College of Gastroenterology

The American Journal of GASTROENTEROLOGY

943